Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. The company was incorporated in 2024 and is headquartered in Waltham, Massachusetts. Show more
Location: 221 Crescent Street Building 23, Waltham, MA, 02453, United States | Website: https://jadebiosciences.com | Industry: Biotechnology | Sector: Healthcare
Market Cap
244.5M
52 Wk Range
$6.57 - $105.00
Previous Close
$7.50
Open
$7.56
Volume
46,504
Day Range
$7.32 - $7.87
Enterprise Value
25.53M
Cash
220.9M
Avg Qtr Burn
-11.31M
Insider Ownership
0.04%
Institutional Own.
99.00%
Qtr Updated
06/30/25
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
JADE101 Details Immunoglobulin A nephropathy (IgAN) | Phase 1 Data readout |